about
Pulmonary nodules and CT screening: the past, present and futureMesenchymal stem cells as vectors for lung cancer therapyTargeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunitiesCADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.Genetically modified mesenchymal stromal cells in cancer therapyTracking genomic cancer evolution for precision medicine: the lung TRACERx studyMacrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering.High prevalence of malignancy in HIV-positive patients with mediastinal lymphadenopathy: a study in the era of antiretroviral therapy.Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesotheliomaAirway stem cells and lung cancer.A general mechanism for intracellular toxicity of metal-containing nanoparticles.Non-small-cell lung cancer resectability: diagnostic value of PET/MR.Smoking is associated with pessimistic and avoidant beliefs about cancer: results from the International Cancer Benchmarking Partnership.Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.Tissue-Engineered Tracheal Replacement in a Child: A 4-Year Follow-Up Study.Transcriptional Profiling of Endobronchial Ultrasound-Guided Lymph Node Samples Aids Diagnosis of Mediastinal LymphadenopathySurface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold.Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.Stochastic homeostasis in human airway epithelium is achieved by neutral competition of basal cell progenitorsLRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development.Impact of EBUS-TBNA on modalities for tissue acquisition in patients with lung cancer.Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds.Tissue engineering airway mucosa: a systematic review.Review of the British Thoracic Society Winter Meeting 2013, 4-6 December, London, UK.Preinvasive disease of the airway.Tracheal Replacement Therapy with a Stem Cell-Seeded Graft: Lessons from Compassionate Use Application of a GMP-Compliant Tissue-Engineered Medicine.Optimized isolation and expansion of human airway epithelial basal cells from endobronchial biopsy samples.Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication.Airway tissue engineering for congenital laryngotracheal disease.Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy.Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.Membrane-spanning DNA nanopores with cytotoxic effect.Epithelial cell migration as a potential therapeutic target in early lung cancer.Cell migration leads to spatially distinct but clonally related airway cancer precursors.BARD1 serum autoantibodies for the detection of lung cancer.
P50
Q26766010-ABFED252-3CD8-4CB0-8AAF-45681908485CQ26853498-B365CB33-3014-4330-82D0-F47F9183E513Q27027433-5DC52028-CF26-4C6E-AC39-EA0D17A62E5AQ27323547-D975E500-2756-4708-BCCC-68BEBCEFB049Q28071840-9E23169E-48B3-4CE3-933C-FB460F59CCD9Q28655985-1865D8C0-B831-43A0-8AC3-24A84A8B075FQ30632123-85CDF5B8-2679-48FA-AB84-C7ED515551ADQ30804681-DFD13728-7056-488A-A581-6A7E6D6F47EDQ33593553-97675115-F56B-4E03-B566-4EE50D35396DQ33623604-5E87253B-B2A7-4C71-AA3E-E5FF70E4D122Q33834736-E05355AF-6046-44A5-AD75-93DB8F01A4EAQ33941770-A209D9C2-2FFC-42B9-9EA7-8A2B0C9603CFQ33995502-023D8398-F011-4C2A-952C-C36DCFB507A6Q34573723-0621DFA4-9250-40D3-B84F-EDB6FEEE0047Q36286008-4EE4E2AC-6AB6-4D26-BF88-4DEF3ABE022CQ36287498-CA0BD2A2-1114-4653-BEAF-08AE358C4BD1Q36532615-E0B3167C-B98A-49FB-98E0-58F9659BA9E9Q36541333-9BF030EB-E96F-46B4-91E8-3042CE92445EQ36603420-F8186542-4F91-4528-A882-26EB9B84CBDCQ36908070-41680523-D57F-4780-AAB3-3C450880F48FQ37000249-F92D69D4-1615-45CE-8EC4-0D41A5B60F3EQ37244130-79334DAB-4579-44C4-8DA8-9285E02DE7D4Q37249599-8A034B72-53D2-48B0-8418-876A6ED313A0Q37595860-26FAE58A-BFE9-4F64-A3B5-2AAB287AC6A5Q37631983-E3FD2465-9509-4DA3-9D49-AEF94B91B4E6Q37675737-7B2A4C18-21E5-42AD-BE0A-938E21A931E8Q38152989-22646DF8-E9C1-4A2B-8F79-0F51AD5B3D6DQ38194480-6E769CD4-295B-40B8-B57E-85C8B3CD19F9Q38658086-10A7CF04-52B7-4E59-A69F-B59F8F5C7728Q38678973-9DB6A63A-441C-46E5-A544-D364FF7DA8FFQ38685715-04B007FD-05AA-4DFF-90AD-748B750F83BAQ38843494-1444C16A-0B65-4C99-AC49-6F26258858A0Q38865190-7299EA6A-9B7F-49B0-ADCC-948C3DA11A08Q38885494-8B2B0B2D-74A9-471F-8497-3C534EF6DCD9Q38888391-40B16975-F1E1-459E-A0DB-3B614997C3B7Q38927008-36AA8E19-2AC2-4F8B-9640-7754FF03E0ACQ38949841-391B764C-43A3-4A84-8FC9-2212116FE334Q39112444-DBFA421A-8966-477A-9606-AA00B62AF86EQ39926329-BE16B75A-46D0-4484-B255-548516F78A3BQ41281453-F23A3D0F-DA93-4DAF-A261-B05CE66140E4
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6634-5939
@en
name
Sam M Janes
@ast
Sam M Janes
@en
Sam M Janes
@nl
type
label
Sam M Janes
@ast
Sam M Janes
@en
Sam M Janes
@nl
prefLabel
Sam M Janes
@ast
Sam M Janes
@en
Sam M Janes
@nl
P106
P31
P496
0000-0002-6634-5939